Source briefingOctober 1, 2026Human Rights
The association between disability and mortality among children and adolescents: A systematic review and meta-analysis

Source briefing · A concise briefing based on one linked source. It is intentionally shorter than a full FreedomWitness Evidence Engine analysis.
What the source reports
by Maureen Moyo-Chilufya, Arthemon Nguweneza, Sara Rotenberg, Hannah Kuper, Tracey Smythe Background Mortality is a fundamental marker of population health and equity. Despite major global declines in mortality over recent decades, disparities in survival persist across childhood and adolescence, particularly by disability status. We aimed to synthesise current evidence on all-cause mortality among children and adolescents with disabilities compared to their non-disabled peers through a systematic review and meta-analysis.
Methods and findings This review was prospectively registered with PROSPERO (CRD420251072039). We searched…
Evidence note: At this stage FreedomWitness is presenting what this source reports. This briefing does not independently prove every underlying claim and should be read together with the original material.
Source & verification
Primary source: PLOS Medicine · September 30, 2026
FreedomWitness links to the original source so readers can inspect the underlying material and judge the context for themselves.
Continue reading

EMA/PE/0000181364
What is established The European Medicines Agency (EMA) has granted a decision regarding a paediatric investigation plan (PIP) for vosoritide as of 8 August…

EMA/PE/0000228795
Evidence Dossier: EMA Paediatric Investigation Plan for Ambrisentan/Tadalafil What is established The European Medicines Agency (EMA) has officially adopted a paediatric investigation plan (PIP)…

EMA/PE/0000261344
Evidence Dossier: EMA Decision on Colchicine Paediatric Investigation Plan (PIP) What is established On 8 August 2025, the European Medicines Agency (EMA) granted a…